Skip to main content
Have a personal or library account? Click to login
miR-548c-5p inhibits proliferation and migration and promotes apoptosis in CD90+ HepG2 cells Cover

miR-548c-5p inhibits proliferation and migration and promotes apoptosis in CD90+ HepG2 cells

Open Access
|Apr 2012

References

  1. Mishra L, Banker T, Murray J, Byers S, Thenappan A, He AR, et al. Liver stem cells and hepatocellular carcinoma.2009;: 318-29.
  2. Marquardt JU, Factor VM, Thorgeirsson SS. Epigenetic regulation of cancer stem cells in liver cancer: Current concepts and clinical implications.2010;: 568-77.
  3. Lingala S, Cui YY, Chen X, Ruebner BH, Qian XF, Zern MA, et al. Immunohistochemical staining of cancer stem cell markers in hepatocellular carcinoma.2010;: 27-35.
  4. Park JR, Kim RJ, Lee YK, Kim SR, Roh KJ, Oh SH, et al. Dysadherin can enhance tumorigenesis by conferring properties of stem-like cells to hepatocellular carcinoma cells.2011;: 122-31.
  5. Ardebili SY, Zajc I, Gole B, Campos B, Herold-Mende C, Drmota S, et al. CD133/prominin1 is prognostic for GBM patient's survival, but inversely correlated with cysteine cathepsins' expression in glioblastoma derived spheroids.2011;: 102-15.
  6. Yang ZF, Ngai P, Ho DW, Yu WC, Ng MN, Lau CK, et al. Identification of local and circulating cancer stem cells in human liver cancer.2008;: 919-28.
  7. Yang ZF, Ho DW, Ng MN, Lau CK, Yu WC, Ngai P, et al. Significance of CD90cancer stem cells in human liver cancer.2008;: 153-66.
  8. Tomuleasa C, Soritau O, Rus-Ciuca D, Pop T, Todea D, Mosteanu O, et al. Isolation and characterization of hepatic cancer cells with stem-like properties from hepatocellular carcinoma.2010;: 61-7.
  9. Kohga K, Tatsumi T, Takehara T, Tsunematsu H, Shimizu S, Yamamoto M, et al. Expression of CD133 confers malignant potential by regulating metallo-proteinases in human hepatocellular carcinoma.2010;: 872-9.
  10. Ma S, Chan KW, Lee TK, Tang KH, Wo JY, Zheng BJ, et al. Aldehyde dehydrogenase discriminates the CD133 liver cancer stem cell populations.2008;: 1146-53.
  11. Na DC, Lee JE, Yoo JE, Oh BK, Choi GH, Park YN. Invasion and EMT-associated genes are up-regulated in B viral hepatocellular carcinoma with high expression of CD133-human and cell culture study.2011;: 66-73.
  12. Chiba T, Kita K, Zheng YW, Yokosuka O, Saisho H, Iwama A, et al. Side population purified from hepatocellular carcinoma cells harbors cancer stem cel1-1ike properties.2006;: 240-51.
  13. Cui F, Wang J, Chen D, Chen YJ. CD133 is a temporary marker of cancer stem cells in small cell lung cancer, but not in non-small cell lung cancer.2011;: 701-8.
  14. Kim CF, Jackson EL, Woolfenden AE, Lawrence S, Babar I, Vogel S, et al. Identification of bronchioalveolar stem cells in normal lung and lung cancer.2005;: 823-35.
  15. Yin S, Li J, Hu C, Chen X, Yao M, Yan M, et al. CD133 positive hepatocellular carcinoma cells possess high capacity for tumorigenicity.2007;: 1444-50.
  16. Suetsugu A, Nagaki M, Aoki H, Motohashi T, Kunisada T, Moriwaki H. Characterization of CD133hepatocel1u1ar carcinoma cells as cancer stem/progenitor cells.2006;: 820-4.
  17. Ma S, Chan KW, Hu L, Lee TK, Wo JY, Ng IO, et al. Identification and characterization of tumorigenic liver cancer stem/progenitor cells.2007;: 2542-56.
  18. Khan MS, Halagowder D, Devaraj SN. Methylated chrysin induces co-ordinated attenuation of the canonical Wnt and NF-kB signaling pathway and upregulates apoptotic gene expression in the early hepatocarcinogenesis rat model.2011;: 12-21.
  19. Hwang HW, Mendell JT. MicroRNAs in cell proliferation, cell death, and tumorigenesis.2006;: 776-80.
  20. Hashimoto T, Kikkawa U, Kamada S. Contribution of caspase(s) to the cell cycle regulation at mitotic phase.2011;: e18449.
  21. Depraetere V, Golstein P. Dismantling in cell death: molecular mechanisms and relationship to caspase activation.2005;: 523-31.
  22. Vaishnav M, MacFarlane M, Dickens M. Disassembly of the JIP1/JNK molecular scaffold by caspase-3-mediated cleavage of JIP1 during apoptosis.2011;: 1028-39.
  23. Rudner J, Elsaesser SJ, Jendrossek V, Huber SM. Anti-apoptotic Bcl-2 fails to form efficient complexes with pro-apoptotic Bak to protect from Celecoxibinduced apoptosis.2011;: 32-42.
  24. Kim R, Emi M, Matsuura K, Tanabe K. Therapeutic potential of antisense Bcl-2 as a chemosensitizer for patients with gastric carcinoma.2005;: 1540-5.
  25. Barrezueta LF, Oshima CT, Lima FO, De Oliveira Costa H, Gomes TS, Neto RA, et al. The intrinsic apoptotic signaling pathway in gastric adenocarcinomas of Brazilian patients: Immunoexpression of the Bcl-2 family (Bcl-2, Bcl-x, Bak, Bax, Bad) determined by tissue microarray analysis.2010;: 261-7.
  26. Chami M, Prandini A, Campanella M, Pinton P, Szabadkai G, Reed JC, et al. Bcl-2 and bax exert opposing effects on Casignaling, which do not depend on their putative pore-forming region.2004;: 54581-9.
  27. Samuel MS, Lopez JI, McGhee EJ, Croft DR, Strachan D, Timpson P, et al. Actomyosin-mediated cellular tension drives increased tissue stiffness and β-catenin activation to induce epidermal hyperplasia and tumor growth.2011;: 776-91.
  28. Lee YS, Mollah ML, Sohn KC, Shi G, Kim DH, Kim KH, et al. Ki-Hwan Kim ID3 mediates X-ray-induced apoptosis of keratinocytes through the regulation of β-catenin.2010;: 138-42.
  29. Luo H, Yang Y, Huang F, Li F, Jiang Q, Shi K, et al. Selenite induces apoptosis in colorectal cancer cells via AKT-mediated inhibition of β-catenin survival axis.2012;: 78-85.
  30. Chan JA, Krichevsky AM, Kosik KS. MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells.2005;: 6029-33.
  31. Bachour T, Bennett K. The role of microRNAs in breast cancer.2011;: 21-8.
  32. Lin Z, Flemington EK. miRNAs in the pathogenesis of oncogenic human viruses.2011;: 186-99.
  33. Kerr TA, Korenblat KM, Davidson NO. MicroRNAs and liver disease.2011;: 241-52.
  34. Huang YS, Dai Y, Yu XF, Bao SY, Yin YB, Tang M, et al. Microarray analysis of microRNA expression in hepatocellular carcinoma and non-tumorous tissues without viral hepatitis.2008;: 87-94.
  35. Gregory PA, Bert AG, Paterson EL, Barry SC, Tsykin A, Farshid G, et al. The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1.2008;: 593-601.
  36. Feitelson MA, Lee J. Hepatitis B virus integration, fragile sites, and hepatocarcinogenesis.2007;: 157-70.
DOI: https://doi.org/10.2478/v10019-012-0025-z | Journal eISSN: 1581-3207 | Journal ISSN: 1318-2099
Language: English
Page range: 233 - 241
Published on: Apr 11, 2012
Published by: Association of Radiology and Oncology
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2012 Lin Fang, Hai-Bing Zhang, Hua Li, Yong Fu, Guang-Shun Yang, published by Association of Radiology and Oncology
This work is licensed under the Creative Commons License.